Datadog’s High Potential Upside And Risks: Why The Stock Is A Hold Now (NASDAQ:DDOG)

pingingz Datadog (NASDAQ:DDOG) is one of the biggest beneficiaries of digital transformation and companies moving to the cloud. Additionally, the proliferation of the Internet of Things (“IoT”) and edge computing is driving a massive increase in machine-generated data, a secular trend that could potentially drive significant future revenue growth for the company’s observability platform. The…

Read More

Alibaba: The AI Bet Has Potential (NYSE:BABA)

David Becker Since the last time I wrote about China’s e-commerce behemoth Alibaba Group Holding (NYSE:BABA) in December last year, its stock price has gone nowhere, with a ~2% decline since. Year-to-date [YTD], it has seen an even bigger fall (see chart below). This is hardly surprising considering that the company’s third quarter (Q3 FY24)…

Read More

STMicroelectronics Is Significantly Undervalued With High Growth Potential (NYSE:STM)

JHVEPhoto There are many semiconductor companies to choose from, and many offer compelling valuations and future operational and financial advantages. However, at this time, STMicroelectronics N.V. (NYSE:STM) looks like one of the most compelling. While TSMC (TSM) has become what I consider overvalued at this time, STM remains positioned for an attractive entry. Overview &…

Read More

Coca-Cola: In Between Reaching Its Current Potential And Acquiring Additional Growth (KO)

jetcityimage Investment Thesis Company Overview Coca-Cola (NYSE:KO), founded in 1886 and headquarters in Atlanta, Georgia, is a total beverage company with its trademark products sold around the world in over 200 countries. Its segments are categorized by geographical locations as well as operation concentration such as Europe, Middle East & Africa (“EMEA”), Latin America (“Latam”),…

Read More

ZIM Integrated: Potential To Double In 2024 (NYSE:ZIM)

Suphanat Khumsap/iStock via Getty Images Shipping logistics provider ZIM Integrated Shipping Services (NYSE:ZIM) reported earnings for the fourth quarter last week that met average investor expectations in terms of adjusted earnings. The company also expectedly reported a large net loss for FY 2023 as the global shipping industry is going through a correction and has…

Read More

ON Semiconductor: Strong Buy, FCF Growth Potential (NASDAQ:ON)

SweetBunFactory I discussed my ‘Strong Buy’ thesis for ON Semiconductor (NASDAQ:ON) in my previous coverage in June 2023, emphasizing their key strengths in carbide and electrification in the auto and industrial end-markets. I forecast the company will deliver double-digit revenue growth and explosive FCF growth over the next few years. I reiterate a ‘Strong Buy’…

Read More

Alibaba Has Substantial Re-Rating Potential In 2024

maybefalse/iStock Unreleased via Getty Images Alibaba Group Holding (NYSE:BABA) has disappointed investors for more than three years as the Chinese economy as well as the eCommerce giant itself under-performed recovery expectations. Alibaba’s sales growth in the fourth quarter was just 5% YoY, down from 9% YoY in September, adding to concerns about a steep growth…

Read More

STAAR Surgical: Potential Buy After Long-Term Valuation Downgrade (NASDAQ:STAA)

YaroslavKryuchka/iStock via Getty Images Investment Overview Back in November 2020, in a post for Seeking Alpha, I gave STAAR Surgical Company (NASDAQ:STAA) (“STAAR”), a manufacturer of intraocular lenses for patients seeking refractive vision correction, a “buy” rating. This was despite noting that, by most investment metrics, its share price looked significantly overvalued. The company’s biggest…

Read More

Microsoft: Strong Financials, Bright Outlook And Solid Upside Potential, Buy (NASDAQ:MSFT)

lcva2 Investment Thesis Microsoft Corporation (NASDAQ:MSFT) is one of the largest and most successful tech companies globally. It is diversified with software, cloud computing hardware, and gaming products. Over the years, the company has been a consistent performer financially which has been reflected in its share prices. For example, its trailing EPS growth rate is…

Read More

2 REITs With Huge Upside Potential

AntonioSolano/iStock via Getty Images REITs are often perceived to be boring income investments that are only suitable for retirees. But the reality is very different The REIT (VNQ) market is vast and versatile with about 1,000 companies worldwide and there is truly something for everyone. There are REITs that are great for conservative income-oriented investors….

Read More

Aemetis: Counting On The Potential (NASDAQ:AMTX)

Parradee Kietsirikul/iStock via Getty Images Investment Thesis Aetemis (NASDAQ:AMTX) has a volatile history with its revenue and earnings, and as recently as the past two years, it was greatly impacted by the volatility of the commodity market more than once. The management has a new five-year plan to address its growth by improving efficiency and…

Read More

Capital Power Stock Offers A 6.7% Yield With Solid Dividend Growth Potential (TSX:CPX:CA)

Bilanol Capital Power is an underappreciated and undervalued dividend growth story as investors focus on the Alberta power market rather than its growth-by-acquisition story. I maintain my buy ranking. Introduction Capital Power (TSX:CPX:CA) is an independent power producer (IPP) which owns 30 operating facilities across North America that generate a collective 7,700 megawatts worth of…

Read More

VIG: Strong Blend Between Capital Appreciation And Dividend Growth Potential

Maryna Terletska/Moment via Getty Images Investment Thesis Vanguard Dividend Appreciation ETF (NYSEARCA:NYSEARCA:VIG) warrants a buy rating due to its low-cost ability to achieve solid performance through capital appreciation and dividend growth. With its inclusion of holdings demonstrating strong growth potential, VIG is postured to outperform many dividend growth competitors including Schwab’s popular U.S. dividend equity…

Read More

trivago: Branded Growth Strategy May Lead Potential Turnaround (NASDAQ:TRVG)

We-Ge/iStock Unreleased via Getty Images trivago (NASDAQ:TRVG), established in 2005, is a leading hotel metasearch engine, aggregating and comparing prices from over 5 million hotels and other types of accommodation across 190 countries. TRVG provides users with comprehensive price comparisons and simplified hotel discovery. TRVG generates revenue by acting as a middleman, connecting users with…

Read More

Madrigal Pharmaceuticals (MDGL): Eli Lilly’s NASH Data Threatens Resmetirom’s Potential

Daniel Christel/iStock via Getty Images Investment Overview Madrigal Pharmaceuticals (NASDAQ:MDGL), the Conshohocken, Pennsylvania based biotech, is the current leader of the “NASH Dash”, that is, the race to secure a first approval for a drug developed to treat nonalcoholic steatohepatitis, or “NASH” an advanced form of non-alcoholic fatty liver disease (“NAFLD”), where buildups of fat…

Read More

PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate (NASDAQ:PETQ)

gilaxia PetIQ (NASDAQ:PETQ) is undergoing a much-needed cost-cutting program as the company continues to support its strong cash-generating product segment while closing inefficient clinics in the services segment. This can put the company on a spiral of higher revenues, higher EBITDA margin, and eventually higher FCF. All these milestones together would support a valuation re-rate…

Read More

Kite Realty REIT Stock: The Yield Is Low, But There Is Potential Here (NYSE:KRG)

WendellandCarolyn Kite Realty Group Trust (NYSE:KRG), founded in 1960 and headquartered in Indianapolis, IN, is a REIT that owns, acquires, (re)develops, and operates open-air shopping centers and mixed-use assets across the country. With a very well-diversified portfolio, remarkable recent growth, and a healthy solvency profile, this REIT seems to have a lot of potential. Additionally,…

Read More

Aurinia Pharmaceuticals: Sales Growth Would Help Buyout Potential (NASDAQ:AUPH)

Aksana Kavaleuskaya/iStock via Getty Images Aurinia Pharmaceuticals (NASDAQ:AUPH) markets Lupkynis (voclosporin) which was approved in January 2021 by the US Food and Drug Administration for the treatment of lupus nephritis. A recent preliminary update on Q4’23 and full-year 2023 financials provides an opportunity to look at where the company stands now. Is it finally time…

Read More